Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -16.42%782.36M | -31.15%694.78M | -51.34%838.22M | 187.79%948.02M | 435.01%936.06M | 409.68%1.01B | --1.72B | 18.91%329.41M | --174.96M | -44.57%197.99M |
Notes receivable and accounts receivable | 28.09%436.72M | 44.11%400.2M | 26.11%395.7M | 38.96%403.05M | 24.42%340.94M | 109.72%277.7M | --313.78M | 37.44%290.05M | --274.02M | -26.77%132.41M |
-Notes receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20M | ---- |
-Accounts receivable | 28.09%436.72M | 44.11%400.2M | 26.11%395.7M | 38.96%403.05M | 34.22%340.94M | 109.72%277.7M | --313.78M | 37.44%290.05M | --254.02M | -26.77%132.41M |
Other receivables (including interest and dividends) | 16.81%30.43M | 58.18%38.9M | -6.29%26.33M | 14.35%30.1M | -8.48%26.05M | 4.97%24.59M | --28.1M | 32.81%26.32M | --28.46M | 76.60%23.43M |
-Other receivable | ---- | ---- | ---- | --30.1M | ---- | 4.97%24.59M | ---- | ---- | ---- | 76.60%23.43M |
Advance payment | 44.72%55.83M | 38.52%38.64M | 32.16%59.93M | 23.61%41.4M | 40.74%38.58M | -35.08%27.89M | --45.34M | -35.05%33.5M | --27.41M | -18.24%42.96M |
Inventories | 15.13%796.06M | 18.75%780.43M | 9.95%746.75M | 25.95%708.99M | 7.03%691.47M | -10.68%657.19M | --679.18M | -15.74%562.91M | --646.04M | 26.16%735.79M |
Non-current assets due within one year | --10.34M | --10.28M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other current assets | 20.42%57.81M | -45.95%53.1M | -1.13%39.5M | 8.69%35.88M | 26.26%48.01M | 206.79%98.25M | --39.95M | 33.61%33.01M | --38.03M | 16.15%32.02M |
Total current assets | 4.25%2.17B | -3.74%2.02B | -25.54%2.11B | 69.97%2.17B | 75.04%2.08B | 79.87%2.09B | --2.83B | 1.84%1.28B | --1.19B | -4.12%1.16B |
Non Current assets | ||||||||||
Other debt investment | 25.98%1.14B | 36.64%1.14B | --880.21M | --864.12M | --908.28M | --832.11M | ---- | ---- | ---- | ---- |
Long-term equity investment | ---- | ---- | -75.16%157.89K | ---- | ---- | ---- | --635.54K | -1.50%636.04K | --637.44K | -10.93%640.75K |
Fixed assets | ---- | ---- | ---- | --889.88M | ---- | -0.55%915.88M | ---- | ---- | ---- | 3.48%920.99M |
Fixed assets liquidation | ---- | ---- | ---- | --384.76K | ---- | ---- | ---- | ---- | ---- | ---- |
Constru in process | ---- | ---- | ---- | --189.31M | ---- | 36.23%33.65M | ---- | ---- | ---- | 369.78%24.7M |
Intangible assets | -1.44%156.27M | 24.19%162.5M | 24.68%163.18M | 22.11%160.65M | 43.32%158.55M | 17.05%130.85M | --130.88M | 15.94%131.56M | --110.63M | -2.96%111.79M |
Long deferred expense | 56.07%22.26M | 77.99%26.07M | 177.35%14.64M | 458.21%15.91M | 233.20%14.26M | 270.12%14.64M | --5.28M | -28.18%2.85M | --4.28M | -84.22%3.96M |
Deferred tax assets | -10.68%37.88M | -3.49%35.36M | 61.10%50.52M | 71.33%46.12M | 36.03%42.41M | 0.62%36.63M | --31.36M | -36.50%26.92M | --31.18M | -23.74%36.41M |
Usufruct assets | 184.40%75.69M | 182.76%77.93M | -2.90%24.73M | 819.28%24.48M | 856.10%26.61M | 848.90%27.56M | --25.47M | -15.38%2.66M | --2.78M | -14.29%2.9M |
Other non current assets | 75.10%175.34M | 184.78%162.9M | 186.85%187.97M | 251.07%170.98M | 612.38%100.14M | 226.72%57.2M | --65.53M | 231.93%48.7M | --14.06M | 1,174.92%17.51M |
Total non current assets | 37.16%3.03B | 46.11%2.99B | 114.41%2.54B | 106.12%2.36B | 100.82%2.21B | 83.08%2.05B | --1.19B | 5.02%1.15B | --1.1B | 2.77%1.12B |
Total assets | 21.19%5.2B | 20.91%5.01B | 15.81%4.65B | 87.08%4.53B | 87.42%4.29B | 81.44%4.14B | 74.36%4.02B | 3.32%2.42B | --2.29B | -0.86%2.28B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | --110M | --110M | ---- | ---- | ---- | ---- | --0 | -87.71%40M | --148.43M | -56.88%164.57M |
Notes payable and accounts payable | 41.57%272.58M | 45.21%267.23M | -2.53%227M | 13.99%232.45M | 36.95%192.53M | 29.74%184.04M | --232.89M | 34.04%203.92M | --140.59M | -30.20%141.85M |
-Notes payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20M | ---- |
-Accounts payable | 41.57%272.58M | 45.21%267.23M | -2.53%227M | 13.99%232.45M | 59.66%192.53M | 29.74%184.04M | --232.89M | 34.04%203.92M | --120.59M | -30.16%141.85M |
Contract liabilities | 57.34%57.47M | 90.77%109.11M | 3.18%31.54M | -11.48%46.14M | 92.29%36.53M | 28.28%57.19M | --30.57M | -6.17%52.12M | --19M | 71.24%44.59M |
Salaries payable | 137.26%88.26M | 88.26%96.74M | 20.63%78.8M | 45.05%59M | 21.33%37.2M | 20.21%51.39M | --65.32M | 31.57%40.68M | --30.66M | 56.28%42.75M |
Taxs payable | 66.61%102.8M | 58.20%67.11M | 89.18%54.11M | 178.24%58.75M | 407.48%61.7M | 476.83%42.42M | --28.6M | -7.98%21.11M | --12.16M | -67.61%7.35M |
Other payable (including interest and dividends) | 59.12%32.57M | 93.13%28.34M | 95.34%25.53M | 551.08%91.75M | 71.59%20.47M | 40.93%14.68M | --13.07M | 26.11%14.09M | --11.93M | -2.73%10.41M |
-Dividend payable | ---- | ---- | ---- | --68.01M | ---- | ---- | ---- | ---- | ---- | ---- |
-Other payable | ---- | ---- | ---- | --23.74M | ---- | 40.93%14.68M | ---- | ---- | ---- | -2.73%10.41M |
Non current liabilities due within one year | 146.50%11.48M | 149.36%11.61M | 59.30%6.39M | 1,160.58%5.78M | --4.66M | 5.40%4.66M | --4.01M | -97.84%458.83K | ---- | -84.59%4.42M |
Other current liabilities | -69.65%997.76K | 61.19%4.66M | -54.25%1.26M | -0.04%2.53M | -33.70%3.29M | -3.26%2.89M | --2.75M | 74.18%2.53M | --4.96M | 187.71%2.99M |
Total current liabilities | 89.73%676.15M | 94.48%694.8M | 12.57%424.61M | 32.41%496.4M | -3.08%356.38M | -14.72%357.26M | --377.21M | -39.61%374.91M | --367.72M | -40.27%418.92M |
Current liabilities | ||||||||||
Long term loan | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | -44.36%27.96M |
Long term salaries pay | -7.50%21.83M | 0.11%19.15M | --35.29M | --33.28M | --23.6M | --19.13M | ---- | ---- | ---- | ---- |
Estimate liabilities | ---- | ---- | ---- | ---- | ---- | ---- | --0 | --550K | --550K | --550K |
Deferred tax liabilities | 16.45%52.79M | 16.50%48.38M | 49.32%54.19M | 39.21%48.55M | 28.63%45.33M | 15.66%41.53M | --36.29M | 8.14%34.88M | --35.24M | 15.55%35.9M |
Long term deferred income | -6.00%30.69M | -9.38%31.51M | -9.00%32.38M | -8.71%33.23M | -12.91%32.64M | -8.57%34.77M | --35.58M | -8.22%36.4M | --37.48M | 2.51%38.03M |
Lease liabilities | 202.57%63.42M | 211.06%64.35M | -22.22%15.33M | 593.80%18.42M | 616.17%20.96M | 580.80%20.69M | --19.71M | -10.14%2.65M | --2.93M | -12.32%3.04M |
Total non current liabilities | 37.69%168.72M | 40.72%163.38M | 49.80%137.19M | 79.21%133.48M | 60.80%122.54M | 10.08%116.11M | --91.58M | -29.98%74.48M | --76.2M | -16.19%105.48M |
Total liabilities | 76.42%844.88M | 81.29%858.18M | 19.84%561.8M | 40.16%629.88M | 7.88%478.91M | -9.73%473.37M | --468.79M | -38.20%449.39M | --443.92M | -36.61%524.4M |
Shareholders equity | ||||||||||
Paid-in capital | 0.00%400.04M | 0.00%400.04M | 0.00%400.04M | 11.11%400.04M | 11.11%400.04M | 11.11%400.04M | --400.04M | 0.00%360.04M | --360.04M | 0.00%360.04M |
Capital reserve funds | 0.72%2.12B | 0.45%2.12B | 0.15%2.11B | 212.84%2.11B | 212.93%2.11B | 213.02%2.11B | --2.11B | 0.16%673.08M | --672.88M | 0.25%672.69M |
Surplus reserve funds | 55.74%61.04M | 57.11%54.1M | 63.88%50.15M | 69.69%43.71M | 74.18%39.19M | 69.13%34.44M | --30.6M | 48.60%25.76M | --22.5M | 161.79%20.36M |
Retained profit | 38.52%1.75B | 39.13%1.55B | 49.44%1.5B | 49.40%1.35B | 60.60%1.26B | 59.08%1.12B | --1.01B | 56.77%902.32M | --784.81M | 56.83%702.08M |
Other composite income | 686.66%14.75M | 152.19%20.72M | 33,120.50%20.37M | -159.85%-3.42M | -278.51%-2.51M | 873.13%8.22M | --61.3K | 149.59%5.71M | ---664.24K | 105.82%844.23K |
Shareholders equity without minority interests | 14.19%4.34B | 13.06%4.14B | 15.25%4.08B | 97.98%3.89B | 106.72%3.8B | 108.72%3.67B | 109.23%3.54B | 21.91%1.97B | --1.84B | 19.29%1.76B |
Minority interests | 47.54%7.67M | 59.03%7.42M | 38.71%5.94M | 12.42%5.36M | 36.79%5.2M | 50.75%4.67M | --4.28M | 81.86%4.77M | --3.8M | -23.66%3.1M |
Total shareholder equity | 14.24%4.35B | 13.12%4.15B | 15.28%4.09B | 97.77%3.9B | 106.58%3.81B | 108.62%3.67B | 109.13%3.55B | 22.01%1.97B | --1.84B | 19.17%1.76B |
Total liabilityies and equity | 21.19%5.2B | 20.91%5.01B | 15.81%4.65B | 87.08%4.53B | 87.42%4.29B | 81.44%4.14B | 74.36%4.02B | 3.32%2.42B | --2.29B | -0.86%2.28B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) | -- | -- | -- | Tianji International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.